gvtcx

National Sickle Cell and Thalassemia Blood Group Genotyping Programme

NHS England Published 26 Sept 2023 Contracts Finder

key details

Value£854,000
Statuscomplete
Category (CPV) 85100000
Deadline10 Jul 2023
Contract start28 Sept 2023
Contract end27 Jul 2024
SME suitableNo
OCIDocds-b5fd17-71fdc68f-174f-4e5a-8e29-cd209a979536

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £854,000.

SupplierValueDateStatus
NHS Blood and Transplant (NHSBT) £854,000 27 Jul 2023 active
NHS Blood and Transplant (NHSBT) · · active

description

The proposed 12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia.

Additional information:

Direct Award justified under Reg 32 as lack of competition due to technical reasons. NHSBT are the only organisation capable of delivering the scope of servcies

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
26 Sept 2023 Contract award notice (F03) Earlier regulations 028436-2023
26 Sept 2023 Award (award) · 5ff577fe-a93a-4fc2-a40e-2607f3244365-683765

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.